Aptose Biosciences, Inc.(Toronto Stock Exchange : APTO)
APTO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-1.82%||67.81||1.0%||$457.29m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.60%||614.38||2.7%||$390.30m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.97%||228.61||1.9%||$331.12m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-4.17%||2.76||0.7%||$192.93m|
|EXAS||EXACT Sciences Corp.||-0.13%||76.03||17.9%||$160.43m|
|ARNA||Arena Pharmaceuticals, Inc.||-0.55%||91.01||13.7%||$137.96m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-0.22%||138.31||8.2%||$131.22m|
|BMRN||BioMarin Pharmaceutical, Inc.||-1.80%||84.45||4.2%||$102.33m|
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.